Myriad Genetics | MYGN - Net Income


Myriad Genetics reported $-7.9M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
Bruker USD 3.5M 22.5M Mar/2026
Danaher USD 1.03B 168M Mar/2026
Illumina USD 134M 200M Mar/2026
J&J USD 5.53B 299M Jun/2026
Mettler Toledo International USD 169.45M 116.31M Mar/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Quidel USD -91.8M 38.9M Mar/2026
Repligen USD 8.33M 4.95M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Standard Biotools USD 127.07M 107.78M Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Veracyte USD 28.71M 12.44M Mar/2026
Waters USD -72M 297.21M Mar/2026